GSK fund manager activity
GSK plc · NYSE. Reported by 10 tracked fund managers in their 13F filings, Q2 2022 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Sarah Ketterer - Causeway Capital Management | Trimmed | 7,163 | $375,470 | 0.00% | Aug 13, 2026 |
| Dodge & Cox Funds | Trimmed | 48,197,514 | $2,526,513,684 | 1.32% | Aug 13, 2026 |
| Ken Fisher - Fisher Asset Management | Added | 35,722,792 | $1,872,588,820 | 0.56% | Aug 4, 2026 |
| Jeremy Grantham - GMO | Added | 3,599,521 | $188,686,891 | 0.43% | Aug 13, 2026 |
| Hillman Capital Management | Trimmed | 92,383 | $4,842,717 | 3.51% | Aug 14, 2026 |
| Kahn Brothers Group | Trimmed | 158,438 | $8,305,319 | 1.31% | Aug 17, 2026 |
| Richard Pzena - Pzena Investment Management | Added | 24,507 | $1,284,635 | 0.00% | Aug 7, 2026 |
| Tweedy Browne | Trimmed | 81,527 | $4,273,645 | 0.32% | Aug 7, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Sarah Ketterer - Causeway Capital Management | Trimmed | 11,110 | $613,177 | 0.01% | May 14, 2026 |
| Dodge & Cox Funds | Trimmed | 58,662,974 | $3,237,609,535 | 1.78% | May 14, 2026 |
| Ken Fisher - Fisher Asset Management | Added | 34,522,363 | $1,905,289,284 | 0.65% | May 5, 2026 |
| Jeremy Grantham - GMO | Added | 3,522,566 | $194,410,418 | 0.50% | May 14, 2026 |
| Hillman Capital Management | Trimmed | 97,432 | $5,377,272 | 3.73% | May 15, 2026 |
| Kahn Brothers Group | Trimmed | 160,982 | $8,884,596 | 1.58% | May 8, 2026 |
| Richard Pzena - Pzena Investment Management | Added | 18,823 | $1,038,836 | 0.00% | Apr 24, 2026 |
| Tweedy Browne | Trimmed | 81,785 | $4,513,714 | 0.36% | May 6, 2026 |
Older quarters